Marjaan General Trading Pharmaceutical Import Profile — United Arab Emirates (DGFT 2022–2026)

Name: Marjaan General Trading Pharmaceutical Import Records from India — 3 Products, $104.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Marjaan General Trading — Pharmaceutical Importer Profile (2026) | 3 Products, $104.6K Trade | TransData Nexus

Marjaan General Trading

Pharmaceutical Importer · United Arab Emirates · Ayurvedic & Herbal Products Focus · $104.6K Total Trade · DGFT Verified

Marjaan General Trading is a pharmaceutical importer based in United Arab Emirates with a total trade value of $104.6K across 3 products in 1 therapeutic categories. Based on 405 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Marjaan General Trading sources from 2 verified Indian suppliers, with Kely Exports And Imports accounting for 74.8% of imports.

Marjaan General Trading — Import Portfolio & Supplier Network

Marjaan General Trading import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Marjaan General Trading?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Kely Exports And Imports	$239.1K	1,637	74.8%
Kely Exports Imports	$80.4K	543	25.2%

Marjaan General Trading sources from 2 verified Indian suppliers across 1,578 distinct formulations. Total import value: $319.4K across 2,180 shipments.

What Formulations Does Marjaan General Trading Import?

Formulation	Value	Ships
Murivenna	$10.0K	7
Karpuradi tailam	$7.6K	4
Murivenna 200ML	$7.1K	7
Kottamchukkadi tailam	$5.7K	4
Dhanwantharam tailam	$5.6K	4
Valiya sahacharadi tailam	$5.3K	2
Kottamchukkadi tailam 200ML	$3.9K	4
Kunkumadi tailam 10ML	$3.6K	6
Karpuradi tailam 200ML	$3.5K	2
Kely herbal products	$3.4K	1
Dhanwantaram tailam	$3.0K	1
Kshirabala tailam	$2.8K	2
Dasamula rasayanam 200GM	$2.8K	5
Zorban oil and haseen oil 100ML +	$2.7K	1
Kottamchukkadi choornam 500GM	$2.5K	4

Marjaan General Trading imports 1,578 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Taila	Ayurvedic & Herbal Products	$87.6K	269	1.2%	10
2	Arishta	Ayurvedic & Herbal Products	$14.1K	88	1.0%	14
3	Ghrita	Ayurvedic & Herbal Products	$2.9K	48	0.6%	13

Marjaan General Trading imports 3 pharmaceutical products across 1 categories into United Arab Emirates totaling $104.6K.

Marjaan General Trading — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Marjaan General Trading, established in 2011 and headquartered in Ajman, United Arab Emirates, is a prominent B2B wholesale supplier specializing in customized products such as uniforms, safety wear, kidswear, fragrances, and Umrah essentials. The company serves a diverse clientele, including businesses, institutions, retailers, and resellers across the UAE and beyond, emphasizing quality products and dependable service.

While Marjaan General Trading's primary focus is on the wholesale supply of customized products, it has also engaged in the importation of pharmaceutical formulations from India. Between 2022 and 2026, the company imported finished pharmaceutical formulations valued at $105,000 USD, comprising 405 shipments. These imports included 1,578 unique formulations across three therapeutic categories, with Ayurvedic and Herbal Products accounting for 100% of the imports. The top three products imported were Taila ($88,000 USD), Arishta ($14,000 USD), and Ghrita ($3,000 USD). The primary suppliers for these products were KELY EXPORTS AND IMPORTS and KELY EXPORTS IMPORTS, accounting for 74.8% and 25.2% of the total import value, respectively.

2Distribution Network

Marjaan General Trading operates from its warehouse located at 25/14, 61 Street, Ajman Industrial 1, Ajman, UAE. (2gis.ae) The company has developed a robust logistics network to support its wholesale operations, ensuring efficient distribution of its diverse product range across the UAE and to international markets. While specific details about its distribution channels are not publicly disclosed, Marjaan's emphasis on fast and flexible supply chains indicates a well-organized logistics framework capable of meeting the demands of its varied clientele.

3Industry Role

In the pharmaceutical supply chain within the UAE, Marjaan General Trading functions as an importer and distributor, focusing on Ayurvedic and Herbal Products sourced from India. The company's role involves importing finished pharmaceutical formulations and distributing them to various stakeholders, including businesses, institutions, and retailers. This positions Marjaan as a key player in the niche market of Ayurvedic and Herbal pharmaceutical products, catering to the growing demand for alternative medicine options in the UAE.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Marjaan General Trading

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Marjaan General Trading's sourcing strategy exhibits a high degree of concentration, with 100% of its pharmaceutical imports originating from two suppliers: KELY EXPORTS AND IMPORTS and KELY EXPORTS IMPORTS. This dual-supplier model suggests a strategic choice to maintain strong, focused relationships with key suppliers, potentially ensuring consistency in product quality and supply reliability. However, the lack of diversification in sourcing could pose risks, such as supply chain disruptions or price fluctuations. The shipment data indicates a stable relationship with these suppliers, as evidenced by the consistent import volumes over the years. Nonetheless, the absence of alternative suppliers may limit Marjaan's ability to negotiate better terms or adapt to market changes swiftly.

2Supply Chain Resilience

Marjaan General Trading's supply chain resilience appears to be moderate. The company's reliance on two primary suppliers for its pharmaceutical imports suggests a focused approach but also indicates potential vulnerabilities. The absence of backup suppliers could lead to challenges in the event of supply disruptions. Additionally, the limited diversity in imported formulations, with 1,578 unique formulations across three therapeutic categories, may restrict the company's ability to adapt to changing market demands. The shipping routes from India to the UAE are well-established, but any geopolitical or logistical issues could impact supply continuity. Regarding regulatory compliance, the key suppliers are expected to adhere to international standards, but specific certifications are not detailed in the available data.

Importing Pharmaceuticals into United Arab Emirates — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Arab Emirates

1Regulatory Authority & Framework

The Emirates Drug Establishment (EDE), established in 2023, is the federal authority overseeing the regulation of pharmaceuticals and medical goods in the UAE. EDE's responsibilities include product approvals, surveillance, and ensuring regulatory compliance within the pharmaceutical sector. Prior to the establishment of EDE, the Ministry of Health and Prevention (MOHAP) was the primary regulatory body governing pharmaceutical products in the UAE. The regulatory framework is designed to ensure that all pharmaceutical products meet the country's quality, safety, and efficacy standards before they can be imported, distributed, or sold in the local market.

2Import Licensing & GMP

Importing pharmaceutical products into the UAE requires the importer to be licensed by the EDE. Only medical stores legally authorized by EDE can import and distribute medicines; medical warehouses can only store, not distribute or sell. Importers must obtain permits from EDE for each shipment, and the documentation includes a Certificate of Analysis (COA), Free Sale Certificate (FSC), Good Manufacturing Practice (GMP) certificate, bills of lading, and packing lists.

3Quality & Labeling

Marjaan General Trading — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Marjaan General Trading's focus on Ayurvedic and Herbal Products aligns with the growing demand for alternative medicine options in the UAE. The imports of Taila, Arishta, and Ghrita suggest a strategic emphasis on traditional remedies that cater to a niche market segment. This product strategy is likely driven by consumer interest in natural and holistic health solutions, as well as the cultural significance of Ayurvedic practices in the region.

2Sourcing Profile

Marjaan General Trading's sourcing strategy for pharmaceutical products is centered on importing finished formulations from India, particularly Ayurvedic and Herbal Products. The company's reliance on two primary suppliers indicates a focused approach to procurement, aiming to maintain strong supplier relationships and ensure product consistency. India's established reputation in the production of Ayurvedic medicines positions it as a key supplier for Marjaan's sourcing needs.

3Market Positioning

Based on its product mix, Marjaan General Trading serves the niche segment of the UAE market that seeks Ayurvedic and Herbal pharmaceutical products. The company's imports are likely distributed through wholesale channels to businesses, institutions, and retailers that cater to consumers interested in alternative medicine options. This positioning allows Marjaan to tap into a growing market segment that values natural and traditional health solutions.

Seller's Guide — How to Become a Supplier to Marjaan General Trading

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the UAE market through Marjaan General Trading. To do so, they would need to offer high-quality products that meet UAE regulatory standards, competitive pricing, and the ability to supply formulations that align with Marjaan's product strategy. Gaps in Marjaan's current sourcing include a limited diversity of formulations and a concentrated supplier base. New suppliers could address these gaps by providing a broader range of products and establishing alternative supply channels, thereby enhancing Marjaan's supply chain resilience.

2Requirements & Qualifications

Indian exporters seeking to supply Marjaan General Trading and the UAE market must ensure that their pharmaceutical products are registered with the Emirates Drug Establishment (EDE) and comply with UAE regulatory standards. Products must undergo batch testing, meet stability requirements, and adhere to labeling mandates in Arabic. Additionally, exporters must provide necessary documentation, including Certificates of Analysis, Free Sale Certificates, and Good Manufacturing Practice (GMP) certificates.

3How to Approach

Frequently Asked Questions — Marjaan General Trading

What products does Marjaan General Trading import from India?

Marjaan General Trading imports 3 pharmaceutical products across 1 categories. Top imports: Taila ($87.6K), Arishta ($14.1K), Ghrita ($2.9K).

Who supplies pharmaceuticals to Marjaan General Trading from India?

Marjaan General Trading sources from 2 verified Indian suppliers. The primary supplier is Kely Exports And Imports (74.8% of imports, $239.1K).

What is Marjaan General Trading's total pharmaceutical import value?

Marjaan General Trading's total pharmaceutical import value from India is $104.6K, based on 405 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Marjaan General Trading focus on?

Marjaan General Trading imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full Marjaan General Trading Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.